Concomitant iGlarLixi and Sodium-Glucose Co-transporter-2 Inhibitor Therapy in Adults with Type 2 Diabetes: LixiLan-G Trial and Real-World Evidence Results.
Cristian GujaFrancesco GiorginoLawrence BlondeAmar AliMartin PráznýJuris J MeierElisabeth SouhamiRobert LubwamaChen JiJulio RosenstockPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2021)
NCT02787551.